Company: CSTL
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001628280-25-048254
Chunk: 121

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-11-03
Form: 10-Q
Item: Item 8
Chunk 121
---
 operations as follows (in thousands):Three Months EndedSeptember 30,Nine Months EndedSeptember 30, 2025202420252024Cost of sales (exclusive of amortization of acquired intangible assets)$1,004 $766 $2,816 $2,058 Research and development90 89 279 258 Selling, general and administrative446 414 1,337 1,147 Total$1,540 $1,269 $4,432 $3,463 

7. Goodwill and Other Intangible Assets, Net

GoodwillWe had a single reporting unit where all goodwill was allocated for as of September 30, 2025 and December 31, 2024. The balance of our goodwill was $10.7 million as of September 30, 2025 and December 31, 2024. There were no accumulated impairments of goodwill as of September 30, 2025 or December 31, 2024.We had a single reportable segment consisting of a single operating segment where the operating segment and the single reporting unit were the same as of September 30, 2025 and December 31, 2024. See Note 15 for additional information on our reportable segment.Other Intangible Assets, NetOur other intangible assets, net consisted of the following (in thousands):September 30, 2025 Gross carrying valueAccumulated amortizationNetWeighted-Average Remaining Life (in years)Developed technology$153,500 $(62,474)$91,026 10.5Assembled workforce563 (431)132 1.2Total other intangible assets, net$154,063 $(62,905)$91,158 

18

Table of ContentsCASTLE BIOSCIENCES, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)(UNAUDITED)

December 31, 2024 Gross carrying valueAccumulated amortizationNetWeighted-Average Remaining Life (in years)Developed technology$125,317 $(29,996)$95,321 8.0Assembled workforce563 (347)216 1.9Total other intangible assets, net$125,880 $(30,343)$95,537 During the first quarter of 2025, we made the decision to discontinue our IDgenetix test offering, effective May 202